Akebia Therapeutics Inc. buy StockNews.com
Start price
20.04.24
/
50%
€1.28
Target price
20.04.25
-
Performance (%)
-4.92%
Price
02.05.24
€1.22
Summary
This prediction is currently active. With a performance of -4.92%, the BUY prediction for Akebia Therapeutics Inc. by StockNews_com is down slightly. This prediction currently runs until 20.04.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Akebia Therapeutics Inc. | -2.170% |
| iShares Core DAX® | 0.000% |
| iShares Nasdaq 100 | 0.626% |
| iShares Nikkei 225® | 1.568% |
| iShares S&P 500 | 0.334% |
Comments by StockNews_com for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for AKBA provided by MarketBeat